Table 4.
Factors Associated With Guideline Concordance Regarding Duration of Secondary Prophylaxis Against RHD Among Clients Age 35 Years and Older
| Variable | Prophylaxis Concordant With Guidelines | Prophylaxis not Concordant With Guidelines | P Value |
|---|---|---|---|
| Overall, No. | 234/343 | 109/343 | |
| Age, median (IQR), y | 42 (37–47) | 42 (38–49) | .471 |
| Region, by remoteness, No. (%) | |||
| Urban | 54/81 (67) | 27/81 (33) | .731 |
| Rural/remote | 180/262 (68) | 82/262 (31) | |
| Region, by site, No. (%) | |||
| Central region | 66/85 (78) | 19/85 (22) | .031 |
| Northern region | 168/258 (65) | 90/258 (35) | |
| Time since last ARF, median (IQR), y | 5.9 (1.3–18.9) | 24.0 (17.1–21.8) | <.001 |
| Age at last ARF, mean (95% CI) | 32.0 (30.2–33.8) | 19.4 (17.1–21.8) | <.001 |
| Years since last echocardiogram, median (IQR) | |||
| Priority 1 | 0.86 (0.47–1.61) | 1.21 (0.69–2.10) | |
| Priority 2 | 0.87 (0.40–1.31) | 1.71 (0.66–4.85) | <.001 |
| Priority 3 | 1.09 (0.57–2.36) | 5.79 (2.99–12.18) | |
| Years since last cardiologist review, median (IQR) | |||
| Priority 1 | 0.71 (0.34–1.39) | 0.95 (0.47–2.31) | |
| Priority 2 | 0.70 (0.41–1.23) | 2.45 (0.66–4.67) | <.001 |
| Priority 3 | 1.14 (0.63–2.89) | 7.42 (1.95–15.2) | |
| Days since last BPG, median (IQR) | 21 (13–34) | 42 (14–115) | .012 |
Abbreviations: ARF, acute rheumatic fever; BPG, benzathine penicillin G; CI, confidence interval; IQR, interquartile range; RHD, rheumatic heart disease.